Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 5
2005 8
2006 13
2007 10
2008 12
2009 8
2010 10
2011 10
2012 12
2013 12
2014 16
2015 11
2016 3
2017 3
2019 2
2020 2
2021 4
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 23339296

121 results

Results by year

Filters applied: . Clear all
Page 1
Anti-cyclic citrullinated peptide antibody titer predicts time to rheumatoid arthritis onset in patients with undifferentiated arthritis: results from a 2-year prospective study.
Bizzaro N, Bartoloni E, Morozzi G, Manganelli S, Riccieri V, Sabatini P, Filippini M, Tampoia M, Afeltra A, Sebastiani G, Alpini C, Bini V, Bistoni O, Alunno A, Gerli R; Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA Group). Bizzaro N, et al. Arthritis Res Ther. 2013 Jan 22;15(1):R16. doi: 10.1186/ar4148. Arthritis Res Ther. 2013. PMID: 23339296 Free PMC article.
Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP, van der Woude D, Ioan-Facsinay A, Levarht EW, Stoeken-Rijsbergen G, Huizinga TW, Toes RE, van der Helm-van Mil AH. van der Linden MP, et al. Arthritis Rheum. 2009 Aug;60(8):2232-41. doi: 10.1002/art.24716. Arthritis Rheum. 2009. PMID: 19644872 Free article.
Anti-cyclic citrullinated peptide antibody predicts the development of rheumatoid arthritis in patients with undifferentiated arthritis.
Li C, Zhang Y, Song H, Gao J, Zhao DB, Zhu Q, He DY, Wang L, Li XP, Liu XD, Xiao WG, Wu XY, Wu HX, Tu W, Hu SX, Wang X, Li ZJ, Lu ZM, Da ZY, Liang B, Liu XM, Zhao JW, Li L, Han F, Qi WF, Wei W, Ma X, Li ZB, Zheng GM, Zhang FX, Li Y, Wang YL, Ling GH, Chen JW, Hou XQ, Zhang J, Chen QP, Liu CL, Zhang Y, Zeng JS, Zou QH, Fang YF, Su Y, Li ZG. Li C, et al. Chin Med J (Engl). 2019 Dec 20;132(24):2899-2904. doi: 10.1097/CM9.0000000000000570. Chin Med J (Engl). 2019. PMID: 31855969 Free PMC article.
Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis.
Kudo-Tanaka E, Ohshima S, Ishii M, Mima T, Matsushita M, Azuma N, Harada Y, Katada Y, Ikeue H, Umeshita-Sasai M, Miyatake K, Saeki Y. Kudo-Tanaka E, et al. Clin Rheumatol. 2007 Oct;26(10):1627-33. doi: 10.1007/s10067-007-0558-5. Epub 2007 Feb 8. Clin Rheumatol. 2007. PMID: 17286215
The diagnostic utility of matrix metalloproteinase-3 and high-sensitivity C-reactive protein for predicting rheumatoid arthritis in anti-cyclic citrullinated peptide antibody-negative patients with recent-onset undifferentiated arthritis.
Hiura K, Iwaki-Egawa S, Kawashima T, Fujisawa S, Takeda T, Komori H, Watanabe Y. Hiura K, et al. Rheumatol Int. 2013 Sep;33(9):2309-14. doi: 10.1007/s00296-013-2716-1. Epub 2013 Mar 17. Rheumatol Int. 2013. PMID: 23503938
121 results